A prospective study of over 72,000 participants found that women who consumed more than three cups of coffee per day had a 20% reduced risk for BCC, while men had a nine percent risk reduction. The study suggests that coffee consumption may be an important option to help prevent BCC.
A meta-analysis of 18 studies found that acetaminophen use was associated with a 33% increased risk for renal cell carcinoma, while nonaspirin NSAIDs were linked with a 26% increased risk. Aspirin use showed no significant association.
Researchers found a strong association between tanning bed use and an increased risk for three common skin cancers: basal cell carcinoma, squamous cell carcinoma, and melanoma. The study tracked 73,494 nurses who used tanning beds during high school and college, finding that more frequent exposure led to higher risks.
A recent study found that high fluid intake is associated with a 24% reduced risk for bladder cancer among male participants. The association was strongest among younger men and may be due to the flushing out of potential carcinogens by fluids.
Research suggests that adding ascorbate to hot dogs reduces N-nitroso compounds, potentially linked to colon cancer. However, colon cancer incidence rates have not changed since 1978.
A study found that a specific dietary pattern, characterized by high red meat and fish intake, sugar-sweetened beverages, and low coffee and whole grain consumption, may increase a woman's risk for colorectal cancer. This pattern was associated with higher levels of C-peptide in the blood, which can promote cell growth and multiplication.
Researchers found that postmenopausal women who gained 61 pounds or more in adulthood had an almost fourfold increased risk for endometrial cancer. Weight cycling, defined as yo-yo dieting, did not increase risk, contrary to previous suggestions.
Researchers found that an antiparasitic agent used to treat African sleeping sickness may provide long-term protection against nonmelanoma skin cancers. The study, conducted on 209 participants, showed a reduced incidence of skin cancers among those who took the drug for five years compared to those who received a placebo.
Research found associations between obesity and increased risk of non-Hodgkin lymphoma in young adults. Diets high in trans fats and low in vegetables were also linked to a higher risk, while those with high vegetable intake had a lower risk. Obesity was particularly strong in men, who had a 64% higher risk of developing NHL.
Postmenopausal women who used nonsteroidal anti-inflammatory drugs for at least 10 years had a significantly lower risk of death from colorectal cancer compared to those who did not use these medications. The study found that consistent NSAID use over time was associated with a 30% lower rate of colorectal cancer mortality.
Andrew J. Dannenberg, M.D., is recognized for his seminal contributions to understanding the inflammation-cancer connection and developing strategies to prevent breast cancer. His work has provided key insights into the role of prostaglandin biology in cancer prevention.
A study published in Cancer Prevention Research found that ginger root supplements reduced markers of colon inflammation in patients, suggesting its potential as a colon cancer prevention agent. The researchers measured standard levels of colon inflammation and found statistically significant reductions in most of these markers.
A combination of P16 immunohistochemistry and DNA qPCR has been found to accurately determine oropharyngeal squamous cell carcinoma, a form of head and neck cancer derived from HPV16. This test outperforms existing methods with high sensitivity and specificity, making it a valuable tool for clinicians.
A study found that MRI screenings detected more breast cancer cases than mammography in high-risk, underserved women. The use of MRI also increased patient compliance with follow-up care. Lowering the cost of MRI may make this screening method more accessible to underinsured populations.
Research suggests that genetic variations in mRNA and microRNA play a critical role in prostate cancer disparities between African-American and white men. The findings could lead to more specialized treatment options for African-American patients.
A study found that African-American men living in low-sunlight areas are more likely to have vitamin D deficiency. Researchers recommend stratified recommendations to consider group differences, as skin composition affects vitamin D production.
Researchers discovered that precancerous cells in high-risk African-American women consume high amounts of glucose and have activated insulin signaling pathways. Conditions like obesity and gestational diabetes can stimulate these cells, but exercise, weight loss, and metformin may help prevent aggressive breast cancer.
Black women are more likely to develop a second breast cancer, even if they were not previously diagnosed with the disease. The average age for this development is significantly lower in black women compared to white women.
Foreign-born US women showed higher mammography screening rates over time, increasing from 60.2% in 2000 to 65.5% in 2008, according to a study by Pennsylvania State University researchers. However, disparities persist between immigrant and native-born women, highlighting the need for improved access to healthcare and insurance coverage.
Research reveals a strong association between stress and tumor aggressiveness in black and Hispanic breast cancer patients, compared to white patients. The study found that higher levels of psychosocial stress were linked to more aggressive tumors, suggesting potential impact on treatment outcomes.
Researchers have identified common genetic variants associated with the development of high-risk neuroblastoma and poor treatment outcomes in patients of African ancestry. These variants may also affect patients of other ethnic backgrounds, highlighting the importance of personalized medicine.
Researchers found that minority patients who develop adult leukemia die from it more often than white patients, with blacks having a 45% greater risk of death from ALL and Hispanics having a 46% greater risk. The study used the SEER database to examine statistics from 40,951 patients with acute leukemia over a 10-year period.
A recent study found that depression is a significant barrier to preventive health screening among Latina breast cancer survivors. The research revealed that Hispanic breast cancer patients are more depressed than their non-Hispanic counterparts and have lower rates of screening for colorectal and ovarian cancers.
The study reveals that EGFR plays a crucial role in the development of KRAS-driven pancreatic cancer, blocking its progression without it. Researchers found that mice with EGF receptor deletion had blocked pancreatic cancer development.
Researchers have discovered how the Merkel cell carcinoma virus operates, offering a potential new approach to treating this rare and aggressive skin cancer. The study found that the virus can cause abnormal cell growth even after removing key interaction sites with heat-shock proteins.
Researchers found that glioblastoma cells need large amounts of cholesterol to grow and survive. Cholesterol-manipulating drugs could potentially lead to significant tumor cell death if this laboratory work is confirmed in larger studies.
Researchers discovered that genes interact with each other in complex pathways, which can help breast cancer progress. Targeting multiple pathways may lead to more effective combination therapies against the disease. A diuretic used to treat hypertension also showed promise in stopping cancer cell progression.
Researchers have discovered that the vaccinia virus construct GLV-1h153 can be used to image and treat pancreatic cancer. The study found that hNIS-mediated radiouptake noninvasively imaged with PET provided information into tumor therapeutic response.
Scientists have developed a novel protein called HER2-Affitoxin that targets HER2-positive cancer cells without interfering with the signaling pathway. The protein has shown promising results in killing tumor cells and is warranting clinical trials.
A study published in Cancer Research found that PTEN helps remove DNA damage caused by UVB radiation, a risk factor for non-melanoma skin cancer. Increasing PTEN activity through supplements or pharmaceuticals may prevent skin cancer.
A study published in Clinical Cancer Research found that trastuzumab, chemotherapy, and surgery significantly improved overall survival in HER2-positive breast and brain cancer patients. Treatment with these therapies led to improved survival rates of up to 20 months for those with central nervous system metastases.
A study published in Cancer Research suggests that stem cell therapy can improve cognitive function in patients with brain cancer who experience radiation-induced learning and memory loss. The treatment involved human neural stem cell transplants, which led to significant improvements in cognitive function compared to control rats.
A recent study found that celecoxib reduced the Ki-67 labeling index by 34% in former smokers, indicating a potential chemopreventive effect against lung cancer. The medication was also linked to a reduction in lung nodules, a precursor to cancer.
Researchers have discovered that complex changes in TP53 occur earlier than previously thought, setting the stage for additional abnormalities. This finding could help scientists determine which mutations lead to precancerous lesions and invasive carcinomas.
Patients treated with sunitinib and sorafenib showed an antibody response comparable to healthy participants, indicating the flu vaccine is safe and effective. This finding has broad implications for patient management beyond targeted therapy.
Researchers used time-lapse video microscopic technology to observe early stages of ovarian cancer metastasis. The study identified the force-dependent processes necessary for tumor cells to attach to and proliferate on organs in the peritoneum.
A low-carbohydrate, high-protein diet has been shown to slow the growth of tumors and reduce the risk of cancer in mice. The study found that restricting carbohydrate intake can limit blood glucose and insulin, promoting tumor growth. A low-carb diet also boosted the immune system's ability to kill cancer cells and prevented obesity.
A recent study found that men who walk briskly after diagnosis have a 57% lower rate of progression of disease than those who walk at an easy pace. Brisk walking can delay or even prevent progression of prostate cancer.
A blood test has identified seven plasma biomarkers that can predict the risk of metastasis in melanoma patients. The test was tested on 216 individuals and showed a high accuracy rate of 0.898, indicating its potential for use in clinical settings.
An observational study found that women with poor physical health scores had a 27% increased risk of cancer recurrence or new breast cancer. Physical health also impacted survival, with a 65% greater risk of death among those with poorer health scores.
A Phase III study found that GOLFIG increased progression-free survival to 16.5 months, compared to 7.5 months with FOLFOX regimen. Researchers added gemcitabine and granulocyte-macrophage colony stimulating factor to boost immune system.
Researchers found that eating six months of freeze-dried strawberries decreased histological grade of precancerous lesions and reduced cancer-related molecular events. The study suggests that strawberries may be a safe and effective chemopreventive agent for esophageal cancer prevention.
Breast cancer survivors who experience extreme weight gain have an increased risk of death and cancer recurrence. Moderate weight gain did not affect breast cancer outcomes, according to a study presented at the AACR 102nd Annual Meeting.
A recent study published by the American Association for Cancer Research found that consuming soy food did not increase the risk of cancer recurrence or death among breast cancer survivors. In fact, women who consumed more soy isoflavones had a reduced risk of mortality and cancer recurrence compared to those with lower intake levels.
A large case-control study found that taking aspirin at least once a month can reduce the risk of pancreatic cancer by 26% compared to non-users. The effect was also seen in those taking low-dose aspirin for heart disease prevention, with a 35% lower risk.
Researchers have developed a novel biomarker test that can detect proteins secreted from tumors caused by asbestos exposure with high accuracy. The test, which uses aptamer proteomics platform, showed an 80% sensitivity rate in detecting stage 1 or 2 malignant pleural mesothelioma, a type of aggressive and often fatal lung cancer.
A new study confirms that genetic differences exist in breast tissue across racial groups, which may explain disparities in breast cancer morbidity and mortality. The research found varying levels of genes related to the DNA repair pathway, a known mechanism in cancer.
Researchers found that heavy beer drinkers with a certain genetic variant were at higher risk of developing non-cardia gastric cancer. The study also showed that non-drinkers with the same gene variant had an elevated risk of gastric cancer.
Researchers have developed a method to assess breast cancer risk using epithelial cells found in breast milk. The study showed that average RASSF1 methylation levels were higher in biopsied breasts compared to non-biopsied breasts, suggesting a potential correlation between epigenetic signals and breast cancer risk.
A recent study presents a promising serum test that can identify lung cancer in people who have never smoked. The test uses a panel of biomarkers to analyze blood samples and has shown high sensitivity and specificity in distinguishing lung cancer from non-cancerous conditions.